Dr. Swisher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- Memorial Hermann - Texas Medical CenterFellowship, Thoracic Surgery, 1994 - 1996
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1986 - 1993
- University of California San Diego School of MedicineClass of 1986
Certifications & Licensure
- CA State Medical License 1988 - Present
- FL State Medical License 2021 - Present
- GA State Medical License 2022 - 2026
- TX State Medical License 1994 - 2026
- AZ State Medical License 2022 - 2025
- LA State Medical License 2023 - 2025
- MS State Medical License 2022 - 2025
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 281 citationsWorldwide esophageal cancer collaboration.Thomas W. Rice, Valerie W. Rusch, Carolyn Apperson-Hansen, Mark S. Allen, L. Q. Chen
Diseases of the Esophagus. 2009-02-01 - 93 citationsIncreased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.Ashraful Hoque, Scott M. Lippman, Tsung Teh Wu, Ya Xu, Zheng D. Liang
Carcinogenesis. 2005-04-01 - 18 citationsMajor pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy.Apar Pataer, Ruping Shao, Arlene M. Correa, Carmen Behrens, Jack A. Roth
Cancer Medicine. 2018-06-01
Journal Articles
- Inhibition of thioredoxin/thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione HomeostasisJohn V Heymach, Stephen G Swisher, Jack A Roth, John D Minna, Clinical Cancer Research
- Landscape of EGFR -Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Post-Progression in EGFR-Mutant NSCLCStephen G Swisher, Vassiliki A Papadimitrakopoulou, John V Heymach, Jack A Roth, Jianjun Zhang, William N William, Bonnie S Glisson, Clinical Cancer Research
- Validation of the 12-Gene Predictive Signature for Adjuvant Chemotherapy Response in Lung CancerCesar Moran, Jack A Roth, Yang Xie, John D Minna, Vassiliki A Papadimitrakopoulou, John V Heymach, Stephen G Swisher, Clinical Cancer Research
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: